Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00585949 · ClinicalTrials.gov registry record

Age and Endothelial Progenitor Cell Mobilization

A clinical trial of Coronary Artery Disease, sponsored by Emory University.

Completed
Registry status
123
Enrollment target
2
Study locations

NCT00585949 is a study of Coronary Artery Disease that has completed, run by Emory University. The registered enrollment target is 123 participants, below the 1,286-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (90% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00585949, a study of Coronary Artery Disease, has completed, sponsored by Emory University.

COMPLETED
Registry status
123 participants
Enrollment target
2
Study locations

Study Summary

It is hypothesized that aging is associated with reduced vascular injury-induced endothelial progenitor cell activity, resulting in impaired vascular repair and increased vascular disease. Patients with stable coronary artery disease will be enrolled in this observational study and will undergo either angiography alone or angiography and angioplasty. Participants will be followed for 5 years.

Conditions Studied

Interventions

  • PROCEDURE Angiography
  • PROCEDURE Percutaneous Coronary Angioplasty

Study Locations (2)

Georgia

  • Atlanta VA Medical Center - Atlanta
  • Emory University Hospital - Atlanta

Trial Details

FieldValue
Enrollment Target 123 participants
Start Date 2006-07
Est. Completion 2008-10-09

Sponsor

Emory University

1,208 total trials

What the Registry Record Tells You About NCT00585949

The ClinicalTrials.gov registry entry for NCT00585949 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 123 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,286-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (90% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 2 interventions - of which Angiography is the first listed.

NCT00585949 reports 2 study locations spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT00585949 about?

NCT00585949 is a clinical study titled "Age and Endothelial Progenitor Cell Mobilization". It is hypothesized that aging is associated with reduced vascular injury-induced endothelial progenitor cell activity, resulting in impaired vascular repair and increased vascular disease. Patients with stable coronary artery disease will be enrolled in this observational study and will undergo eith...

What is the current status of trial NCT00585949?

This trial is currently completed. The enrollment target is 123 participants. The study started on 2006-07. Estimated completion is 2008-10-09.

What conditions does trial NCT00585949 study?

This clinical trial studies the following conditions: Coronary Artery Disease.

What interventions are being tested in trial NCT00585949?

The interventions under investigation include: Angiography (PROCEDURE), Percutaneous Coronary Angioplasty (PROCEDURE).

Who is sponsoring clinical trial NCT00585949?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00585949 being conducted?

This trial has 2 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.